BioCentury
ARTICLE | Company News

Hybridon news

August 29, 1994 7:00 AM UTC

Privately held Hybridon received a $2.85 million loan guarantee from the Massachusetts Emerging Technology Fund program to develop a 36,000 square foot manufacturing plant in Milford, Mass. The plant will produce GEM 91, the company's lead antisense oligonucleotide to treat HIV and AIDS. ...